 |
 |
 |
 |
- site map glossary
ask your veterinarian about LTCI
*Lymphocyte T-Cell Immunomodulator has received a conditional license from the United States Department of Agriculture. Additional efficacy and
potency studies are in progress. LTCI is manufactured by T-Cyte Therapeutics, Inc. and is exclusively distributed by IMULAN BioTherapeutics, LLC.
A promotional campaign for IMULAN’s Feline Leukemia and
Feline AIDS treatment aid executed via Google and Yahoo PPC
ads helped stimulate awareness among afflicted cat owners and
trial among veterinarians unaware of the new treatment.
Save on Lymphocyte T-Cell Immunomodulator (LTCI), the first and only conditionally approved treatment aid in the United States for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) infections. For every order placed by a veterinarian until June 15, 2008, we will match that order with free product.
Lymphocyte T-Cell Immune Modulator is intended as an aid in the treatment of cats infected with feline leukemia virus (FeLV) and/or feline immunodeficiency virus (FIV), and the associated symptoms of lymphopenia, opportunistic infection, anemia, granulocytopenia, or thrombocytopenia.
To order LTCI, or for more information, visit IMULAN.com, or call 877.892.9595.
 |
|
 |
|
|
© 2010 Lukaska Strategy + Design